UA72916C2 - Nasal drops containing genetically engineered interferon as antiviral substance - Google Patents

Nasal drops containing genetically engineered interferon as antiviral substance

Info

Publication number
UA72916C2
UA72916C2 UA2001106977A UA2001106977A UA72916C2 UA 72916 C2 UA72916 C2 UA 72916C2 UA 2001106977 A UA2001106977 A UA 2001106977A UA 2001106977 A UA2001106977 A UA 2001106977A UA 72916 C2 UA72916 C2 UA 72916C2
Authority
UA
Ukraine
Prior art keywords
genetically engineered
nasal drops
drops containing
antiviral substance
containing genetically
Prior art date
Application number
UA2001106977A
Other languages
English (en)
Inventor
Petro Yakovych Haponiuk
Illia Oleksandrovych Markov
Original Assignee
Petro Yakovych Haponiuk
Illia Oleksandrovych Markov
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Petro Yakovych Haponiuk, Illia Oleksandrovych Markov filed Critical Petro Yakovych Haponiuk
Publication of UA72916C2 publication Critical patent/UA72916C2/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
UA2001106977A 1999-01-25 1999-09-06 Nasal drops containing genetically engineered interferon as antiviral substance UA72916C2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
RU99100666A RU2140285C1 (ru) 1999-01-25 1999-01-25 Противовирусное средство - капли в нос "гриппферон"
PCT/RU1999/000320 WO2000054798A1 (en) 1999-01-25 1999-09-06 Antiviral agent in the form of nose drops

Publications (1)

Publication Number Publication Date
UA72916C2 true UA72916C2 (en) 2005-05-16

Family

ID=20214625

Family Applications (1)

Application Number Title Priority Date Filing Date
UA2001106977A UA72916C2 (en) 1999-01-25 1999-09-06 Nasal drops containing genetically engineered interferon as antiviral substance

Country Status (14)

Country Link
US (2) USRE40882E1 (de)
EP (1) EP1314436B1 (de)
CN (1) CN1166405C (de)
AT (1) ATE434441T1 (de)
AU (1) AU776182B2 (de)
CA (1) CA2372099C (de)
CY (1) CY1110352T1 (de)
DE (1) DE69941033D1 (de)
DK (1) DK1314436T3 (de)
ES (1) ES2329204T3 (de)
PT (1) PT1314436E (de)
RU (1) RU2140285C1 (de)
UA (1) UA72916C2 (de)
WO (1) WO2000054798A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2187330C1 (ru) * 2000-12-18 2002-08-20 Гапонюк Петр Яковлевич Противовирусное средство
RU2195315C2 (ru) * 2001-02-28 2002-12-27 Московский областной научно-исследовательский клинический институт Способ лечения орви у детей первого года жизни
US20040037809A1 (en) * 2002-06-28 2004-02-26 Nastech Pharmaceutical Company Inc. Compositions and methods for enhanced mucosal delivery of interferon beta
RU2220739C1 (ru) * 2002-08-30 2004-01-10 Гапонюк Петр Яковлевич Интраназальное средство
RU2220738C1 (ru) * 2002-08-30 2004-01-10 Гапонюк Петр Яковлевич Средство для лечения ринита
RU2220740C1 (ru) * 2002-08-30 2004-01-10 Гапонюк Петр Яковлевич Средство для лечения аллергического ринита и аллергического конъюнктивита
EP1765382A1 (de) * 2004-06-07 2007-03-28 Nastech Pharmaceutical Company Inc. Intranasale formulierungen von interferon beta ohne stabilisatoren, die proteine oder polypeptide sind
EP1951285A2 (de) * 2005-11-18 2008-08-06 Ares Trading S.A. Interferon bei grippe
EP2464406B1 (de) * 2009-08-10 2016-10-26 Proviflo, LLC Katheter-locklösungen mit tocopherol und mittelketten-fettsäuren
RU2437676C1 (ru) * 2010-07-27 2011-12-27 Илья Александрович Марков Противовирусное средство - капли в нос
RU2488405C1 (ru) * 2012-07-17 2013-07-27 Илья Александрович Марков Лекарственное средство, обладающее противовирусным, противовоспалительным, иммуномодулирующим и обезболивающим действием, для местного и наружного применения - герпферон 2
RU2554495C2 (ru) * 2013-03-11 2015-06-27 Илья Александрович Марков Цитокинсодержащее лекарственное средство, обладающее противовирусным, противомикробным, иммуномодулирующим и противовоспалительным действием для профилактики и лечения инфекционных заболеваний
WO2016169571A1 (en) * 2015-04-20 2016-10-27 Ghaleb Haider Abbas Pharmaceutical product for treatment & prophylaxis of viral/ microbial infection
EP3307374A4 (de) 2015-06-11 2019-04-10 Proviflo, LLC Graft-port-hämodialysesysteme, -vorrichtungen und -verfahren
RU2768656C1 (ru) * 2021-09-10 2022-03-24 Илья Александрович Марков Противовирусное средство в жидкой форме и способ его приготовления

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1234383A (en) * 1982-03-17 1983-09-22 Inter-Yeda Ltd. Interferon stabilised with polyvinyl-pyrrolidone
US4476116A (en) * 1982-12-10 1984-10-09 Syntex (U.S.A.) Inc. Polypeptides/chelating agent nasal compositions having enhanced peptide absorption
JPS59163313A (ja) * 1983-03-09 1984-09-14 Teijin Ltd 経鼻投与用ペプチドホルモン類組成物
US4855238A (en) 1983-12-16 1989-08-08 Genentech, Inc. Recombinant gamma interferons having enhanced stability and methods therefor
US4857316A (en) * 1984-10-03 1989-08-15 Syntex (U.S.A.) Inc. Synergistic antiviral composition
US4710376A (en) 1985-02-01 1987-12-01 Interferon Sciences, Inc. Topical therapeutic composition containing oxidation inhibitor system
GB8803365D0 (en) * 1988-02-13 1988-03-16 Ciba Geigy Ag Antiviral combination
US5059418A (en) * 1989-09-20 1991-10-22 The Administrators Of The Tulane Educational Fund Synergistic effect of human recombinant interferon-beta on halogenated pyrimidines
CA2033725C (en) * 1990-01-24 2001-05-29 Folker Pittrof Pharmaceutical and cosmetic compositions containing a salt of cholanic acid
US5372808A (en) 1990-10-17 1994-12-13 Amgen Inc. Methods and compositions for the treatment of diseases with consensus interferon while reducing side effect
RU2020957C1 (ru) * 1991-05-14 1994-10-15 Нестерова Ирина Вадимовна Способ лечения персистирующих вирусных заболеваний
RU2020967C1 (ru) 1991-06-10 1994-10-15 Научно-производственное объединение прикладной механики Устройство для вакуум-массажа
RU2033180C1 (ru) 1991-07-04 1995-04-20 Научно-исследовательский институт эпидемиологии и микробиологии им.Н.Ф.Гамалеи Способ реабилитации больных лучевым поражением
RU2095081C1 (ru) * 1991-12-13 1997-11-10 Акционерное общество "Биофа" Фармацевтическая композиция антивирусного действия
RU2057544C1 (ru) 1992-02-11 1996-04-10 Научно-производственное предприятие "Тринита" Препарат для лечения вирусных, хламидийных и бактериальных инфекций
RU2097061C1 (ru) * 1992-02-11 1997-11-27 Научно-производственное предприятие "Тринита" Лекарственный препарат для лечения вирусных инфекций
RU2022562C1 (ru) 1992-05-06 1994-11-15 Рубальский Олег Васильевич Способ лечения вирусной инфекции кожи и слизистых оболочек
RU2077336C1 (ru) * 1994-12-06 1997-04-20 Государственный научно-исследовательский институт прикладной микробиологии Препарат генноинженерного гамма-интерферона
RU2073522C1 (ru) 1995-07-20 1997-02-20 Олег Васильевич Рубальский Лекарственный препарат противовирусного действия
RU2108804C1 (ru) 1997-06-24 1998-04-20 Общество с ограниченной ответственностью "Свет Софт Био" Препарат "локферон" для лечения и профилактики вирусных заболеваний и способ его получения
DE19733651A1 (de) * 1997-08-04 1999-02-18 Boehringer Ingelheim Pharma Wässrige Aerosolzubereitungen enthaltend biologisch aktive Markomoleküle und Verfahren zur Erzeugung entsprechender Aerosole

Also Published As

Publication number Publication date
EP1314436A4 (de) 2003-05-28
CA2372099C (en) 2011-10-18
US6635243B1 (en) 2003-10-21
EP1314436A1 (de) 2003-05-28
RU2140285C1 (ru) 1999-10-27
WO2000054798A1 (en) 2000-09-21
ATE434441T1 (de) 2009-07-15
AU776182B2 (en) 2004-09-02
CY1110352T1 (el) 2015-04-29
AU5766599A (en) 2000-10-04
ES2329204T3 (es) 2009-11-23
CN1344165A (zh) 2002-04-10
PT1314436E (pt) 2009-09-28
CN1166405C (zh) 2004-09-15
DE69941033D1 (de) 2009-08-06
USRE40882E1 (en) 2009-08-25
DK1314436T3 (da) 2009-11-02
EP1314436B1 (de) 2009-06-24
CA2372099A1 (en) 2000-09-21

Similar Documents

Publication Publication Date Title
UA72916C2 (en) Nasal drops containing genetically engineered interferon as antiviral substance
PL352257A1 (en) Imidazoquinolines substituted by urea
YU60900A (sh) Novi kristalni oblici antivirusnog benzimidazolskog jedinjenja
PL351796A1 (en) Solutions of polyurethane resins with alkoxysilate-type structural units
DK0654991T3 (da) Inhalationspulver indeholdende antistatisk hjælpemiddel
YU52099A (sh) Fungicidni trifluormetilalkilamino-triazolpirimidini
EP0186439A3 (en) Heat-curable silicone compositions, use thereof and stabilizer therefor
MXPA04005412A (es) Imidazopiridinas sustituidas por urea.
NZ213113A (en) Substituted benzimidazoles, intermediates, and pharmaceutical compositions
AU2003297199A8 (en) Human chondroitinase glycoprotein (chasegp), process for preparing the same, and pharmaceutical compositions comprising thereof
DE69835929D1 (de) Beta-galaktosid alpha-2,6-sialyltransferase kodierendes gen
AU2003227595A1 (en) Foam control agents
UA87813C2 (ru) Система контролируемого высвобождения темозоломида
DE3560313D1 (en) Improvements in or relating to anticonvulsant agents
Turner et al. Microleakage of dentin-amalgam bonding agents.
NZ502862A (en) Optically pure camptothecin analogues, optically pure synthesis intermediate and method for preparing same
GB1503856A (en) Pharmaceutical composition containing trimethoprim sulphamethoxazole and alpha-amylase
IL138327A0 (en) Metal-containing ribonucleotide polypeptides
MD1473F2 (en) Antiherpetic remedy
AP1579A (en) Novel 17-Halogenated 19-nor steroids, method and intermediates for preparing same, use as medicines and pharmaceutical compositions containing same.
TW282449B (de)
MY131055A (en) An adhesive composition comprising isocyanate, phenol- formaldehide and tannin, useful for manufacturing plywoods for exterior application
DE50003506D1 (de) Glaspulver und dessen Verwendung
IT8619329A0 (it) Fermaglio di tipo invisivile per bracciale, in particolare per bracciale-orologio.
IT8248381A0 (it) Perfezionamento nei sistemi indossabili per la infusione prolungata di medicamenti, ad esempio insulina